1. Home
  2. UFCS vs ARCT Comparison

UFCS vs ARCT Comparison

Compare UFCS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFCS
  • ARCT
  • Stock Information
  • Founded
  • UFCS 1946
  • ARCT 2013
  • Country
  • UFCS United States
  • ARCT United States
  • Employees
  • UFCS N/A
  • ARCT N/A
  • Industry
  • UFCS Property-Casualty Insurers
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • UFCS Finance
  • ARCT Health Care
  • Exchange
  • UFCS Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • UFCS 642.7M
  • ARCT 602.7M
  • IPO Year
  • UFCS N/A
  • ARCT N/A
  • Fundamental
  • Price
  • UFCS $28.95
  • ARCT $15.48
  • Analyst Decision
  • UFCS Hold
  • ARCT Strong Buy
  • Analyst Count
  • UFCS 1
  • ARCT 7
  • Target Price
  • UFCS $26.00
  • ARCT $65.00
  • AVG Volume (30 Days)
  • UFCS 154.0K
  • ARCT 412.0K
  • Earning Date
  • UFCS 02-11-2025
  • ARCT 11-07-2024
  • Dividend Yield
  • UFCS 2.21%
  • ARCT N/A
  • EPS Growth
  • UFCS N/A
  • ARCT N/A
  • EPS
  • UFCS 1.94
  • ARCT N/A
  • Revenue
  • UFCS $1,207,451,000.00
  • ARCT $160,399,000.00
  • Revenue This Year
  • UFCS N/A
  • ARCT $6.91
  • Revenue Next Year
  • UFCS $11.31
  • ARCT $5.24
  • P/E Ratio
  • UFCS $14.90
  • ARCT N/A
  • Revenue Growth
  • UFCS 10.95
  • ARCT N/A
  • 52 Week Low
  • UFCS $18.04
  • ARCT $14.30
  • 52 Week High
  • UFCS $31.70
  • ARCT $45.00
  • Technical
  • Relative Strength Index (RSI)
  • UFCS 50.15
  • ARCT 38.67
  • Support Level
  • UFCS $30.11
  • ARCT $14.30
  • Resistance Level
  • UFCS $31.35
  • ARCT $20.92
  • Average True Range (ATR)
  • UFCS 0.92
  • ARCT 1.27
  • MACD
  • UFCS -0.54
  • ARCT -0.26
  • Stochastic Oscillator
  • UFCS 8.33
  • ARCT 17.82

About UFCS United Fire Group Inc.

United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Share on Social Networks: